Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

NCT00003465 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: temozolomide

Sponsor

Duke University

Collaborators

[object Object]